(Q78571623)
Statements
A randomized, double-blind, placebo-controlled phase III study evaluating efficacy and tolerability of 2 courses of alefacept in patients with chronic plaque psoriasis (English)
Gerald G Krueger
Dow B Stough
Keith H Loven
Wayne P Gulliver
Charles N Ellis
Alefacept Clinical Study Group
1 December 2002